US NIH Resumes Indian Trials But Keen On 'Elaborations' Of Rules

More than two years after it cut back on Indian clinical trials, the US National Institutes of Health, the largest public funder of biomedical research in the world, appears to have recommenced activity in the area, albeit on a cautious note.